A Study to Evaluate Iloperidone for the Treatment of Parkinson's Disease Psychosis

Stopped Study was terminated for business reasons; not due to safety or efficacy concerns.

Conditions

• Parkinson Disease Psychosis

Interventions

• DRUG: Iloperidone

Sponsor

Vanda Pharmaceuticals